v3.25.1
Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details)
1 Months Ended 12 Months Ended
Oct. 16, 2024
shares
Oct. 07, 2024
Aug. 26, 2024
Jun. 05, 2024
tradingDay
shares
Sep. 06, 2023
Nov. 30, 2021
USD ($)
stockholder
shares
Mar. 31, 2025
USD ($)
nonemployee_Director
$ / shares
shares
Mar. 31, 2024
USD ($)
officer
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Feb. 28, 2022
nonemployee_Director
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Reverse stock split 0.05 0.05                
Share based payment, noncash expense             $ 62,027,000 $ 120,209,000 $ 116,017,000  
Current liabilities of discontinued operations             $ 0 $ 21,372,000    
Weighted-average grant date fair values of options granted (in usd per share) | $ / shares             $ 4.09 $ 17.40 $ 48.49  
Intrinsic value of vested options exercised             $ 0 $ 1,400,000 $ 4,600,000  
Unrecognized stock-based compensation cost             $ 11,700,000      
Weighted average period over which unrecognized compensation is expected to be recognized             2 years      
Stock-based compensation expense             $ 59,285,000 108,498,000 99,981,000  
Lemonaid Health, Inc.                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Award vesting period           4 years        
Lemonaid Health, Inc. | Former Lemonaid Officer                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Unrecognized stock-based compensation cost               $ 0    
Former officers terminated | officer               2    
Stock-based compensation expense               $ 25,100,000    
Lemonaid Health, Inc. | Former Lemonaid Officer | General and administrative                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Stock-based compensation expense               28,400,000 11,000,000  
Discontinued Operations                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Stock-based compensation expense             2,700,000 11,700,000 16,000,000.0  
Current liabilities of discontinued operations             0 21,372,000    
Minimum                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Reverse stock split     0.200              
Maximum                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Reverse stock split     0.0333              
Stock Options                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Tax benefit from stock option exercise             $ 0 $ 0 0  
Restricted Stock Units                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Granted (in shares) | shares             3,797,604      
Weighted average period over which unrecognized compensation is expected to be recognized             2 years 7 months 6 days      
Unrecognized stock-based compensation cost             $ 30,700,000      
Performance Shares                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Performance period (in years)             1 year      
Common Stock Class A | Lemonaid Health, Inc.                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Common stock granted subject to vest (in shares) | shares           187,352        
Aggregate grant date fair value           $ 43,900,000        
Common Stock Class A | Lemonaid Health, Inc. | Former Lemonaid Officer                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Former stockholders who were granted shares | stockholder           2        
A and R Plan | Common Stock Class A                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Number of shares authorized (in shares) | shares 10,034,656                  
Second A And R Plan                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Percentage of shares automatically added annually         5.00%          
Non-employee directors, electing to defer settlement of RSUs | nonemployee_Director                   2
Non-employee directors, eligible to participate in the program | nonemployee_Director             0      
Second A And R Plan | Stock Options                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Share-based payment award, expiration period         10 years          
Stock options exercise price, percentage         100.00%          
Number of shares of common stock received for each option exercised         1          
Second A And R Plan | Stock Options | Minimum                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Award vesting period         3 years          
Second A And R Plan | Stock Options | Maximum                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Award vesting period         4 years          
Second A And R Plan | Restricted Stock Units | Minimum                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Award vesting period         1 year          
Second A And R Plan | Restricted Stock Units | Maximum                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Award vesting period         4 years          
Annual Incentive Plan | Restricted Stock Units                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Performance period               1 year    
Granted (in shares) | shares       607,222            
Share based payment, noncash expense             $ 5,200,000 $ 5,200,000 14,900,000  
Other current liabilities for awards             5,300,000 5,800,000    
Current liabilities of discontinued operations             0 700,000    
Annual Incentive Plan | Restricted Stock Units | Discontinued Operations                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Stock-based compensation expense             $ 100,000 $ 700,000 $ 4,100,000  
Annual Incentive Plan | Common Stock Class A                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Days preceding date of payment | tradingDay       20            
ESPP                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Number of shares authorized (in shares) | shares 580,456                  
ESPP | Employee Stock                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Common stock issued and outstanding percentage 1.00%                  
Potential annual increase in shares reserved for future issuance (in shares) | shares 250,000                  
A And R ESPP                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Shares issued (in shares) | shares             212,862 266,473 132,141  
Average exercise price (in usd per share) | $ / shares             $ 2.88 $ 12.24 $ 48.92  
Weighted average grant date fair value (in usd per share) | $ / shares             $ 2.52 $ 8.74 $ 27.02  
A And R ESPP | Employee Stock                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
ESPP concurrent offering period             12 months      
ESPP successive purchase period             6 months